期刊文献+

注射用头孢西丁钠杂质谱分析方法影响因素探讨

Study on the influence factors of impurity profiles of cefoxitin sodium for injection
下载PDF
导出
摘要 目的采用计算机辅助设计试验,考察影响注射用头孢西丁钠有关物质色谱分析方法的主要因素并使目标因子达到最优,对注射用头孢西丁钠杂质谱分析方法进行优化。方法制备系统适用性混合溶液,确定目标因子。通过Plackett-Burman(PB)设计筛选显著因素;通过中心组合设计(CCD)设计进行优化并确定最佳色谱条件;采用质谱法分析有关物质结构。结果色谱柱参数、流动相参数和梯度程序等因素均对杂质分离分析有较大影响;在建立的最优色谱条件下,11个潜在杂质均能得到有效分离并被检测。杂质谱分析显示,不同企业产品杂质谱存在差异。结论使用计算机辅助设计优化色谱分析方法,可实现对潜在杂质的有效分析,为完善注射用头孢西丁钠质量标准和质量控制提供了指导。 Objective The computer-aided design experiment was used to investigate the main factors affecting the chromatographic analysis of related substances in cefoxitin sodium for injection and to optimize the objective attributes,and the impurity profile analysis method was optimized.Methods The system suitability solution was prepared,and the objective attributes was determined.The Plackett-Burman(PB)design was used to screen for significant factors,and the Central Composite Design(CCD)design was adopted to determine optimal chromatographic conditions.Mass spectrometry was used to identify the structure of the related substances.Results The column parameters,mobile phases,and the gradient program had great influences on the separation and analysis of impurities.With the optimal chromatographic conditions established,11 potential impurities were effectively separated and detected.Impurity profiles analysis showed that there were differences in the impurity profiles of samples produced by different enterprises.Conclusion The use of computer-aided design in optimizing chromatographic method can facilitate the effective analysis of potential impurities.The article provided the guidance for cefoxitin sodium for injection standard improvement and quality control of the preparation.
作者 杨妹妹 李玮 李姜晖 鲁曙光 黄鹏 Yang Mei-mei;Li Wei;Li Jiang-hui;Lu Shu-guang;Huang Peng(Anhui Provincial Institute for Food and Drug control,Hefei 230051;Anhui University of Traditional Chinese Medicine,Hefei 230012;Anhui Sifo Pharmaceutical Co.,Ltd,Hefei 230088)
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2023年第3期308-316,共9页 Chinese Journal of Antibiotics
基金 2021年安徽省药品监督管理局科技创新技术攻关项目(No.AHYJ-KJ-202104)。
关键词 头孢西丁钠 试验设计 杂质谱 有关物质 HPLC Cefoxitin sodium Design of experiments Impurity profiles Related substances HPLC
  • 相关文献

参考文献9

二级参考文献124

  • 1陈军,胡高云,杨华.注射用头孢西丁钠有关物质测定方法的改进[J].中南药学,2007,5(2):121-123. 被引量:7
  • 2中华人民共和国药典委员会编.中国药典第二部.附录34-35[M].北京:化学工业出版社,2005.
  • 3JX20010299.进口药品注册标准[S].
  • 4ChP(中国药典).2010.VolⅡ(二部):922.
  • 5European Pharmacopoeia Commission. 01/2005 : 0990 European Pharmacopoeia [ S]. 5th ed. Strasbourg. EDQM,2004.1216-1217.
  • 6Lau WY, Fan ST, Chu KW,et al. Cefoxitin versus gentamicin and met- ronidazole in prevention of post - appendicectomy sepsis : a random- ized, prospective trial. J Antimicrob Chemother, 1986,18 (5) :613.
  • 7Romano A, Tortes M J, Namour F, et al. Immediate hypersensitivity to cephalosporins. Allergy, 2002,57 ( 72 ) : 52.
  • 8Van Krimpen PC ,Van Bennekom WP,Buh A. Penicillins and ceph- alosporins, physicochemical properties and analysis in phamaceutical and biological matrices. Pharm Weekbl(Sci) , 1987,9 ( 1 ) : 1.
  • 9The ICH Steering Committee. ICH harmonised tripartite guideline: impurities in drug substances [ EB/OL ]. 2006 - 10 -25 [ 2009 - 10 - 08 ]. http : //www. ich. org/LOB/media/MEDIA422, pdf.
  • 10USP 34 - NF 29. 2236.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部